Unexpected advantages of less accurate performance measurements. How simple prescription data works in a complex setting regarding the use of medications

Public Administration

Volumn 90, Issue 2, 2012, Pages 497-510

  De Bont, Antoinette ^a   Grit, Kor ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GOVERNANCE APPROACH; PERFORMANCE ASSESSMENT; PUBLIC SERVICE; SCIENCE AND TECHNOLOGY;

EID: 84862673366     PISSN: 00333298     EISSN: 14679299     Source Type: Journal    
DOI: 10.1111/j.1467-9299.2011.01959.x     Document Type: Article

References (49)

1. Bevan, G. and C. Hood 2006. 'What's Measured is what Matters: Targets and Gaming in the English Public Health Care System', Public Administration, 84, 3, 517-38.
2. Callon, M. 1999. 'Actor-Network Theory - the Market Test', in J. Law and J. Hassard (eds), Actor Network Theory and After. Oxford: Blackwell/The Sociological Review, pp. 181-95.
3. Callon, M. 2001. 'Writing and (Re)writing Devices as Tools for Managing Complexity', in J. Law and A. Mol (eds), Complexities in Science, Technology and Medicine. Durham, NC: Duke University Press.
4. Carter, N. 1994. 'Performance Indicators: "Backseat Driving" or "Hands Off" Control?', in D. McKevitt and A. Lawton (eds), Public Sector Management. Theory, Critique and Practice. London: Sage.
5. Clarke, A. 2005. Situational Analysis. Grounded Theory after the Postmodern Turn. Thousand Oaks, CA: Sage.
6. Cohen, D., M. McCubbin, J. Colli and G. Perodeau 2001. 'Medications as Social Phenomena', Health, 5, 4, 441-69.
7. De Bont, A., K. Grit and H. Stoevelaar 2006. Sturingsinstrumenten voor zorgverzekeraars. Een bestuurskundige analyse van de mogelijkheden om het farmacotherapeutisch overleg te optimaliseren. Rotterdam: iBMG, Erasmus University Rotterdam.
8. De Bruijn, D. 2007. Managing Performance in the Public Sector. London: Routledge.
9. DGV. 2005. FTO module Maagklachten, afbouwen van onterecht chronisch gebruik van maagzuurremmers. Werk materiaal voor een FTO bijeenkomst. Utrecht: DGV.
10. DGV. 2007. FTO Peiling 2007. Farmacotherapieoverleg in 2007. Utrecht: DGV.
11. Dubnick, M. 2005. Accountability and the Promise of Performance: In Search for the Mechanisms, Public Performance and Management Review, 28, 3, 376-417.
12. Foucault, M. 1988. Politics, Philosophy, Culture: Interviews and Other Writings of Michel Foucault, 1977 - 1984 London: Routledge.
13. Fox, N., K. Ward and A. O'Rourke 2006. 'A Sociology of Technology Governance for the Information Age: The Case of Pharmaceuticals, Consumer Advertising and the Internet', Sociology, 40, 2, 315-34.
14. Gullick, L. 1936. 'Introduction', in L. Harrison and E. Lane (eds), After Repeal: A Study of Liquor Control Legislation. New York: Harper, pp. i-xxxv.
15. Helderman, J. and F. Schut 2005, 'Market-oriented Health Care Reforms and Policy Learning in the Netherlands', Journal of Health Politics, Policy & Law, 30, 1-2, 189-221.
16. IGZ. 2003. Voorwaarden voor verantwoorde farmaceutische zorgverlening door openbare apothekers onderzocht. The Hague: IGZ.
17. Jansen, J., L. Van Dijk, C. Wagner and D. de Bakker (eds). 2004. Professionalisering van het FTO in Noord-Holland-Noord. Utrecht: NIVEL.
18. Jasanoff, S. 2007. Designs on Nature: Science and Democracy in Europe and the United States. Princeton, NJ: Princeton University Press.
19. Jos, P. and M. Tomkins 2004. 'The Accountability Paradox in an Age of Reinvention', Administration & Society, 26, 3, 255-81.
20. Kanter, R.M. and D.V. Summers 1994. 'Doing Well While Doing Good: Dilemmas of Performance Measurement in Nonprofit Organizations and the Need for a Multiple-constituency Approach', in D. McKevitt and A. Lawton (eds), Public Sector Management. Theory, Critique and Practice. London: Sage.
21. Klein, R. and N. Carter 1988. 'Performance Measurement: A Review of Concepts and Issues', in D. Beeton (ed.), Performance Measurement: Getting the Concepts Right. London: Public Finance Foundation.
22. Latour, B. 1987. Science in Action: How to Follow Scientists and Engineers through Society. Cambridge, MA: Harvard University Press.
23. Latour, B. 1995. 'The "Pedofil" of Boa Vista: A Photo-Philosophical Montage', Common Knowledge 4, 1, 145-87.
24. Lindgren, L. 2001. 'The Non-profit Sector Meets the Performance-management Movement: A Programme-theory Approach', Evaluation, 7, 3, 285-303.
25. MacKenzie, D. 2003. 'An Equation and its Worlds: Bricolage, Exemplars, Disunity and Performativity in Financial Economics', Social Studies of Science, 33, 12, 831-68.
26. MacKenzie, D. 2007. 'Is Economics Performative? Option Theory and the Construction of Derivatives Markets', in D. Mackenzie, F. Munesia and L. Siu (eds), Do Economists Make Markets? On the Performativity of Economics. Princeton, NJ: Princeton University Press, pp. 54-86.
27. Metz, J., P. Smet and J. Tinke 2005. Het ontwikkelen, implementeren van praktijkprogramma's rond FTO en FPZ. The Hague: KNMP.
28. Muijrers, P., J. Knottnerus, J. Sijbrandij, et al. 2004. 'Pharmacists in Primary Care. Determinants of the Care-providing Function of Dutch Community Pharmacists in Primary Care', Pharmacy World Science, 26, 5, 256-62.
29. Niezen, M., A. de Bont and H. Stoevelaar 2005. Evaluatie MJA deeltraject. Het waarborgen en verbeteren van de kwaliteit van de farmaceutische zorg. Rotterdam: IBMG.
30. NIVEL. 2004. Professionalisering van het FTO in Noord-Holland Noord. Utrecht: NIVEL.
31. NIVEL. 2005. Doelmatig voorschijven van antidepressiva in de huisartspraktijk. Utrecht: NIVEL.
32. Noordegraaf, M. and T. Abma 2007. 'Management by Measurement? Public Management Practices Amidst Ambiguity', Public Administration, 81, 4, 853-71.
33. Paes, A. and P. Cornips 1987. 'Ontstaan en verloop van farmocotherapie-overleg', Pharmaceutisch weekblad, 122, 10, 225-30.
34. Poster, M. 2004. 'The Information Empire', Comparative Literature Studies, 41, 3, 317-33.
35. Power, M. 1997. The Audit Society: Rituals of Verification. Oxford: Oxford University Press.
36. Pronk, M., L. Blom, R. Jonkers, et al. 2002. 'Patient Oriented Activities in Dutch Community Pharmacy: Diffusion of Innovations', Pharmacy World Science, 24, 4, 154-61.
37. Radder, H. 1998. 'The Politics of STS', Social Studies of Science, 28, 2, 325-8.
38. Radin, B. 2006. Challenging the Performance Movement. Accountability, Complexity and Democratic Values. Washington, DC: Georgetown University Press.
39. Rose, N. 1999. Powers of Freedom. Reframing Political Thought. Cambridge: Cambridge University Press.
40. Sanderson, I. 2006. 'Complexity, "Practical Rationality" and Evidence-based Policy Making', Policy and Politics: Studies of Local Government and its Services, 34, 1, 115-32.
41. Singh, J.P. 2002. 'Introduction: Information Technologies and the Changing Scope of Global Power and Governance', in J. Rosenau and J. Singh (eds), Information Technologies and Global Politics. Albany, NY: State University of New York Press.
42. Thévenot, L. and L. Boltanski 2006. On Justification. Economies of Worth, Princeton, NJ: Princeton University Press.
43. TNO. 2005. Doelmatig voorschrijven van nieuwe geneesmiddelen; off label voorschrijven van cox-2 remmers als casus. Leiden: TNO.
44. Tuohy, C. 2003. 'Agency, Contract, and Governance: Shifting Shapes of Accountability in the Health Care Arena', Journal of Health Politics, Policy and Law, 28, 2-3, 195-216.
45. Van der Ven, W. and F. Schut 2008. 'Universal Mandatory Health Insurance in The Netherlands: A Model for the United States?', Health Affairs, 27, 3, 771-81.
46. Van Peursem, K.A., M.J. Pratt and S.R. Lawrence 1995. 'Health Management Performance. A Review of Measures and Indicators', Accounting, Auditing and Accountability Journal, 5, 1, 34-70.
47. VWS. 2000. Kabinetstandpunt geneesmiddelenbeleid. GMT/ G2064781. The Hague: VWS.
48. Winthereik, B., I. van der Ploeg and. M. Berg 2007. 'The Electronic Patient Record as a Meaningful Audit Tool: Accountability and Autonomy', Science Technology Human Values, 32, 1, 6-25.
49. Wrede, S., C. Benoit I., Bourgeault, L. et al. 2006. 'Decentred Comparative Research: Context Sensitive Analysis of Maternal Health Care', Social Science & Medicine, 63, 11, 2986-97.